Literature DB >> 21239441

Differential and complementary effects of glucose and prolactin on islet DNA synthesis and gene expression.

Ramamani Arumugam1, Donald Fleenor, Danhong Lu, Michael Freemark.   

Abstract

The mechanisms by which lactogenic hormones promote β-cell expansion remain poorly understood. Because prolactin (PRL) up-regulates β-cell glucose transporter 2, glucokinase, and pyruvate dehydrogenase activities, we reasoned that glucose availability might mediate or modulate the effects of PRL on β-cell mass. Here, we used male rat islets to show that PRL and glucose have differential but complementary effects on the expression of cell cyclins, cell cycle inhibitors, and various other genes known to regulate β-cell replication, including insulin receptor substrate 2, IGF-II, menin, forkhead box protein M1, tryptophan hydroxylase 1, and the PRL receptor. Differential effects on gene expression are associated with synergistic effects of glucose and PRL on islet DNA synthesis. The effects of PRL on gene expression are mirrored by β-cell overexpression of signal transducer and activator of transcription 5b and are opposed by dexamethasone. An ad-small interfering RNA specific for cyclin D2 attenuates markedly the effects of PRL on islet DNA synthesis. Our studies suggest a new paradigm for the control of β-cell mass and insulin production by hormones and nutrients. PRL up-regulates β-cell glucose uptake and utilization, whereas glucose increases islet PRL receptor expression and potentiates the effects of PRL on cell cycle gene expression and DNA synthesis. These findings suggest novel targets for prevention of neonatal glucose intolerance and gestational diabetes and may provide new insight into the pathogenesis of β-cell hyperplasia in obese subjects with insulin resistance.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21239441      PMCID: PMC3198965          DOI: 10.1210/en.2010-1258

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  72 in total

1.  Pdx1 restores beta cell function in Irs2 knockout mice.

Authors:  Jake A Kushner; Jing Ye; Markus Schubert; Deborah J Burks; Matthew A Dow; Carrie L Flint; Sanjoy Dutta; Christopher V E Wright; Marc R Montminy; Morris F White
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

2.  The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic beta cell growth.

Authors:  Tadahiro Kitamura; Jun Nakae; Yukari Kitamura; Yoshiaki Kido; William H Biggs; Christopher V E Wright; Morris F White; Karen C Arden; Domenico Accili
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

Review 3.  Use of recombinant adenovirus for metabolic engineering of mammalian cells.

Authors:  T C Becker; R J Noel; W S Coats; A M Gómez-Foix; T Alam; R D Gerard; C B Newgard
Journal:  Methods Cell Biol       Date:  1994       Impact factor: 1.441

4.  Signal transducer and activator of transcription 5 activation is sufficient to drive transcriptional induction of cyclin D2 gene and proliferation of rat pancreatic beta-cells.

Authors:  Birgitte N Friedrichsen; Henrijette E Richter; Johnny A Hansen; Christopher J Rhodes; Jens H Nielsen; Nils Billestrup; Annette Møldrup
Journal:  Mol Endocrinol       Date:  2003-02-13

5.  Targeted deletion of the PRL receptor: effects on islet development, insulin production, and glucose tolerance.

Authors:  Michael Freemark; Isabelle Avril; Don Fleenor; Phyllis Driscoll; Ann Petro; Emmanuel Opara; Will Kendall; Jon Oden; Spencer Bridges; Nadine Binart; Bernadette Breant; Paul A Kelly
Journal:  Endocrinology       Date:  2002-04       Impact factor: 4.736

6.  The prolactin receptor in the fetal rat: cellular localization of messenger ribonucleic acid, immunoreactive protein, and ligand-binding activity and induction of expression in late gestation.

Authors:  M Royster; P Driscoll; P A Kelly; M Freemark
Journal:  Endocrinology       Date:  1995-09       Impact factor: 4.736

7.  An adenovirus vector for efficient RNA interference-mediated suppression of target genes in insulinoma cells and pancreatic islets of langerhans.

Authors:  James R Bain; Jonathan C Schisler; Koji Takeuchi; Christopher B Newgard; Thomas C Becker
Journal:  Diabetes       Date:  2004-09       Impact factor: 9.461

8.  Insulin-like growth factor-II gene expression in a rat insulin-producing beta-cell line (INS-1) is regulated by glucose.

Authors:  M Asfari; W De; M Nöel; P E Holthuizen; P Czernichow
Journal:  Diabetologia       Date:  1995-08       Impact factor: 10.122

9.  Pancreatic beta-cells in obesity. Evidence for induction of functional, morphologic, and metabolic abnormalities by increased long chain fatty acids.

Authors:  J L Milburn; H Hirose; Y H Lee; Y Nagasawa; A Ogawa; M Ohneda; H BeltrandelRio; C B Newgard; J H Johnson; R H Unger
Journal:  J Biol Chem       Date:  1995-01-20       Impact factor: 5.157

10.  Growth dynamics of pancreatic islet cell populations during fetal and neonatal development of the rat.

Authors:  H L Kaung
Journal:  Dev Dyn       Date:  1994-06       Impact factor: 3.780

View more
  10 in total

1.  Knockdown of prolactin receptors in a pancreatic beta cell line: effects on DNA synthesis, apoptosis, and gene expression.

Authors:  Ramamani Arumugam; Don Fleenor; Michael Freemark
Journal:  Endocrine       Date:  2013-10-12       Impact factor: 3.633

2.  Pathogenesis of growth failure and partial reversal with gene therapy in murine and canine Glycogen Storage Disease type Ia.

Authors:  Elizabeth Drake Brooks; Dianne Little; Ramamani Arumugam; Baodong Sun; Sarah Curtis; Amanda Demaster; Michael Maranzano; Mark W Jackson; Priya Kishnani; Michael S Freemark; Dwight D Koeberl
Journal:  Mol Genet Metab       Date:  2013-04-06       Impact factor: 4.797

3.  Glucose Induces Mouse β-Cell Proliferation via IRS2, MTOR, and Cyclin D2 but Not the Insulin Receptor.

Authors:  Rachel E Stamateris; Rohit B Sharma; Yahui Kong; Pantea Ebrahimpour; Deepika Panday; Pavana Ranganath; Baobo Zou; Helena Levitt; Nisha Abraham Parambil; Christopher P O'Donnell; Adolfo García-Ocaña; Laura C Alonso
Journal:  Diabetes       Date:  2016-01-06       Impact factor: 9.461

4.  Defective prolactin signaling impairs pancreatic β-cell development during the perinatal period.

Authors:  Julien Auffret; Michael Freemark; Nadège Carré; Yves Mathieu; Cécile Tourrel-Cuzin; Marc Lombès; Jamileh Movassat; Nadine Binart
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-09-24       Impact factor: 4.310

5.  MafA is required for postnatal proliferation of pancreatic β-cells.

Authors:  Koki Eto; Wataru Nishimura; Hisashi Oishi; Haruhide Udagawa; Miho Kawaguchi; Masaki Hiramoto; Toshiyoshi Fujiwara; Satoru Takahashi; Kazuki Yasuda
Journal:  PLoS One       Date:  2014-08-15       Impact factor: 3.240

6.  Prolactin and oleic acid synergistically stimulate β-cell proliferation and growth in rat islets.

Authors:  Todd Clark Brelje; Nicholas V Bhagroo; Laurence E Stout; Robert L Sorenson
Journal:  Islets       Date:  2017-07-07       Impact factor: 2.694

7.  Impact of Gender on the Association between Low Serum Prolactin and Left Ventricular Mass in Subjects with Prediabetes.

Authors:  Mervat M El-Eshmawy; Enas M Elkhamisy; Eman Elsayed; Shaheer Kamal
Journal:  Diabetes Metab J       Date:  2017-06       Impact factor: 5.376

8.  Modeling MEN1 with Patient-Origin iPSCs Reveals GLP-1R Mediated Hypersecretion of Insulin.

Authors:  Ziqi Cheng; Dongsheng Guo; Aynisahan Ruzi; Tingcai Pan; Kai You; Yan Chen; Xinping Huang; Jiaye Zhang; Fan Yang; Lizhi Niu; Kecheng Xu; Yin-Xiong Li
Journal:  Cells       Date:  2022-08-03       Impact factor: 7.666

Review 9.  Modelling gestational diabetes mellitus: large animals hold great promise.

Authors:  Xiang Gao; Junsheng He; Anming Zhu; Kang Xie; Kaixuan Yan; Xue Jiang; Ying Xu; Qin Li; Aimin Xu; Dewei Ye; Jiao Guo
Journal:  Rev Endocr Metab Disord       Date:  2020-11-27       Impact factor: 6.514

10.  Gestational Diabetes Mellitus From Inactivation of Prolactin Receptor and MafB in Islet β-Cells.

Authors:  Ronadip R Banerjee; Holly A Cyphert; Emily M Walker; Harini Chakravarthy; Heshan Peiris; Xueying Gu; Yinghua Liu; Elizabeth Conrad; Lisa Goodrich; Roland W Stein; Seung K Kim
Journal:  Diabetes       Date:  2016-05-23       Impact factor: 9.461

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.